Syensqo, a Belgian advanced materials and specialty chemicals company, serves industrial and consumer applications through Materials and Performance & Care.
Congressman McCormick tours Syensqo as part of the American Chemistry Council’s Responsible Care® Roadshow, which invites policymakers to chemical manufacturing sites. The event demonstrates the industry’s focus on safety, environmental responsibility, and innovation while advocating for policies supporting U.S. manufacturing growth.
Syensqo reports €1.4 billion in net sales for Q1 2026, a 5% sequential increase driven by its Specialty Polymers and Novecare divisions. Underlying EBITDA rises 6% sequentially to €251 million, also led by Specialty Polymers. The company maintains its full-year 2026 underlying EBITDA outlook while reducing capital expenditure by up to €50 million.
Syensqo introduces a long-term incentive (LTI) share buyback program. The initiative allows employees to purchase company shares at a discount as part of their compensation package. This move aligns with broader trends in equity-based incentives for retention and alignment with shareholder interests.
Mike Radossich officially becomes Chief Executive Officer (CEO) of Syensqo, succeeding Ilham Kadri. Kadri will remain as a special advisor to facilitate a leadership transition. The appointment takes effect January 1, 2026, following an earlier announcement made last fall.
Syensqo CEO Ilham Kadri highlights AI and biochemistry as key drivers for the company’s financial growth. The specialty chemicals firm emphasizes integrating advanced technologies to enhance product development and operational efficiency. Kadri underscores the strategic importance of these fields in maintaining competitive advantage and expanding market reach.